BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35589036)

  • 1. A Nomogram for Predicting Early Recurrence in Patients with High-Grade Gliomas.
    Zhou Q; Ke X; Xue C; Li S; Huang X; Zhang B; Zhou J
    World Neurosurg; 2022 Aug; 164():e619-e628. PubMed ID: 35589036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. World Health Organization Grade II/III Glioma Molecular Status: Prediction by MRI Morphologic Features and Apparent Diffusion Coefficient.
    Maynard J; Okuchi S; Wastling S; Busaidi AA; Almossawi O; Mbatha W; Brandner S; Jaunmuktane Z; Koc AM; Mancini L; Jäger R; Thust S
    Radiology; 2020 Jul; 296(1):111-121. PubMed ID: 32315266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Radiomics Analyses Based on Different Magnetic Resonance Imaging Sequences in Grading and Molecular Genomic Typing of Glioma.
    Huang WY; Wen LH; Wu G; Hu MZ; Zhang CC; Chen F; Zhao JN
    J Comput Assist Tomogr; 2021 Jan-Feb 01; 45(1):110-120. PubMed ID: 33475317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Value of a Nomogram Model Based on Apparent Diffusion Coefficient Values Within 1 cm of the Tumor Cavity to Predict Postoperative Progression of Glioma.
    Cheng M; Pang S; Wang Z; Zhao Y; Li W
    World Neurosurg; 2023 Dec; 180():e149-e157. PubMed ID: 37696435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain T1ρ mapping for grading and IDH1 gene mutation detection of gliomas: a preliminary study.
    Cao M; Ding W; Han X; Suo S; Sun Y; Wang Y; Qu J; Zhang X; Zhou Y
    J Neurooncol; 2019 Jan; 141(1):245-252. PubMed ID: 30414094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACTC1 as an invasion and prognosis marker in glioma.
    Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
    J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study.
    Wang Q; Li Q; Mi R; Ye H; Zhang H; Chen B; Li Y; Huang G; Xia J
    J Magn Reson Imaging; 2019 Mar; 49(3):825-833. PubMed ID: 30260592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive Prediction of TERT Promoter Mutations in High-Grade Glioma by Radiomics Analysis Based on Multiparameter MRI.
    Tian H; Wu H; Wu G; Xu G
    Biomed Res Int; 2020; 2020():3872314. PubMed ID: 32509858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging texture analyses in lower-grade gliomas with a commercially available software: correlation of apparent diffusion coefficient and T2 skewness with 1p/19q codeletion.
    Kanazawa T; Minami Y; Takahashi H; Fujiwara H; Toda M; Jinzaki M; Yoshida K; Sasaki H
    Neurosurg Rev; 2020 Aug; 43(4):1211-1219. PubMed ID: 31402410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal MRI-Based Radiomic Nomogram for the Early Differentiation of Recurrence and Pseudoprogression of High-Grade Glioma.
    Jing H; Yang F; Peng K; Qin D; He Y; Yang G; Zhang H
    Biomed Res Int; 2022; 2022():4667117. PubMed ID: 36246986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Main genetic differences in high-grade gliomas may present different MR imaging and MR spectroscopy correlates.
    Bernabéu-Sanz Á; Fuentes-Baile M; Alenda C
    Eur Radiol; 2021 Feb; 31(2):749-763. PubMed ID: 32875375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voxel-based clustered imaging by multiparameter diffusion tensor images for glioma grading.
    Inano R; Oishi N; Kunieda T; Arakawa Y; Yamao Y; Shibata S; Kikuchi T; Fukuyama H; Miyamoto S
    Neuroimage Clin; 2014; 5():396-407. PubMed ID: 25180159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive Prediction of IDH1 Mutation and ATRX Expression Loss in Low-Grade Gliomas Using Multiparametric MR Radiomic Features.
    Ren Y; Zhang X; Rui W; Pang H; Qiu T; Wang J; Xie Q; Jin T; Zhang H; Chen H; Zhang Y; Lu H; Yao Z; Zhang J; Feng X
    J Magn Reson Imaging; 2019 Mar; 49(3):808-817. PubMed ID: 30194745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
    Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
    J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of IDH1 gene mutation by a nomogram based on multiparametric and multiregional MR images.
    Zheng J; Dong H; Li M; Lin X; Wang C
    Clinics (Sao Paulo); 2023; 78():100238. PubMed ID: 37354775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive Assessment of O(6)-Methylguanine-DNA Methyltransferase Promoter Methylation Status in World Health Organization Grade II-IV Glioma Using Histogram Analysis of Inflow-Based Vascular-Space-Occupancy Combined with Structural Magnetic Resonance Imaging.
    He W; Li X; Hua J; Liao S; Guo L; Xiao X; Liu X; Zhou J; Wang W; Xu Y; Wu Y
    J Magn Reson Imaging; 2021 Jul; 54(1):227-236. PubMed ID: 33590929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplified perfusion fraction from diffusion-weighted imaging in preoperative prediction of IDH1 mutation in WHO grade II-III gliomas: comparison with dynamic contrast-enhanced and intravoxel incoherent motion MRI.
    Wang X; Cao M; Chen H; Ge J; Suo S; Zhou Y
    Radiol Oncol; 2020 Jun; 54(3):301-310. PubMed ID: 32559177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning-based quantitative texture analysis of conventional MRI combined with ADC maps for assessment of IDH1 mutation in high-grade gliomas.
    Alis D; Bagcilar O; Senli YD; Yergin M; Isler C; Kocer N; Islak C; Kizilkilic O
    Jpn J Radiol; 2020 Feb; 38(2):135-143. PubMed ID: 31741126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.